DiviDrip · SCLX

SCLX — Scilex Holding Company

SCLX is Scilex Holding Company (Healthcare) — a non-dividend-paying stock. Trading at $5.43. Market cap: $38M. Capital Quality Rank: 41/100 — Stagnant mediocrity.

Stock snapshot

Price$5.43
Market cap$38M
SectorHealthcare
ExchangeNCM
Pays dividendNo

Capital Quality & fundamentals

DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.

Capital Quality Rank (1-100)41 / 100 · Stagnant mediocrity
Revenue CAGR (3y)-18.8%
Shareholder buyback yield0.00%
Altman Z-score zoneDistress

About SCLX

Scilex Holding Co is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. It targets indications with high unmet needs and large market opportunities with non-opioid therapies for the treatment of patients with acute and chronic pain and are dedicated to advancing and improving patient outcomes. Its commercial products are: ZTlidoO for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a potential first-line treatment ready-to-use oral solution for the acute treatment of migraine in adults and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.

Listed2022Employees34HQPalo Alto, CASectorHealthcareWebsitescilexholding.com

Related non-dividend companies

Other non-dividend stocks investors research alongside SCLX. Peer set from Massive news + returns similarity, filtered to names we currently track.

Frequently asked

What is SCLX's current stock price?

SCLX (Scilex Holding Company) is currently trading at $5.43.

Does SCLX pay a dividend?

SCLX (Scilex Holding Company) does not currently pay a regular dividend.

What is SCLX's Capital Quality Rank?

SCLX has a Capital Quality Rank of 41/100 — Stagnant mediocrity. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.

Track SCLX in DiviDrip

Add SCLX to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.

Data refreshed 2026-08-30. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Trademark Notice: Twylight Crow's Dividend Tracker (formerly indexed as DiviDrip) is an independent portfolio utility. This tool is not affiliated with, authorized, endorsed by, or in any way officially connected to Dividrip.com or its international affiliates.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow